This summary describes the key points of the evaluation, while the Science Evaluation of Proposed Registration Decision PRD2022-13, Bacillus amyloliquefaciens strain F727 and Stargus Biofungicide provides detailed technical information on the human health, environmental and value assessments of B. amyloliquefaciens strain F727 and Stargus Fungicide.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Similar records